RECRUITINGINTERVENTIONAL

Metacognitive Therapy for Obsessive-Compulsive Disorder

The Efficacy of Metacognitive Therapy for Obsessive-compulsive Disorder

About This Trial

The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are: Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations? The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD. Participants will: Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks. Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention

Who May Be Eligible (Plain English)

Who May Qualify: - two psychiatrists with the title of Deputy Chief Physician or above jointly determine that the above diagnostic criteria were met - education level of junior high school or above, without mental retardation or audio-visual disorders - participation in the study is voluntary, and the willing to sign a consent form is signed by the patient or his/her guardian Who Should NOT Join This Trial: - loss of or insufficient self-awareness, the presence of hallucinations, delusions, and other psychotic symptoms - the presence of severe depression, or self-inflicted suicidal attempts and behaviors - the presence of a history of alcohol or drug abuse - refusal of psychotherapy, or the ineffectiveness of those who had been involved in a full course of psychotherapy. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * two psychiatrists with the title of Deputy Chief Physician or above jointly determine that the above diagnostic criteria were met * education level of junior high school or above, without mental retardation or audio-visual disorders * participation in the study is voluntary, and the informed consent is signed by the patient or his/her guardian Exclusion Criteria: * loss of or insufficient self-awareness, the presence of hallucinations, delusions, and other psychotic symptoms * the presence of severe depression, or self-inflicted suicidal attempts and behaviors * the presence of a history of alcohol or drug abuse * refusal of psychotherapy, or the ineffectiveness of those who had been involved in a full course of psychotherapy.

Treatments Being Tested

BEHAVIORAL

Metacognitive Therapy

A one-on-one face-to-face dialogue format will be used to conduct psychotherapy with each participant, and the treatment protocol will be based on the treatment manual for metacognitive therapy.

OTHER

General mental health promotion

A general mental health mission will be conducted, not covering any metacognitive therapy related content, set for 8-15 weeks, 1 time per week

Locations (1)

Northeast Normal University

Changchun, Jilin, China